مقارنة بين قيم سرعة تثفّل الكريات الحمر((ESR وقيم البروتين الارتكاسي (C) في مجموعات مرضية ذات تظاهرات التهابية
Abstract
شملت الدراسة 300 مريضٍ من مشفى الأسد الجامعي في محافظة اللاذقية بين عامي 2005-2006 وقد وزِّع المرضى على أربع مجموعات، الأولى: الأمراض الإنتانيةالجرثومية، الثانية: الأمراض الرثوانية، الثالثة: الأمراض الدموية، الرابعة: التنشؤات الورمية. وكان الهدف من الدراسة محاولة إيجاد علاقة بين البروتين الارتكاسي (C) وسرعة تثفّل الكريات الحمر عند المجموعات المرضية ذات التظاهرات الإلتهابية. وقد خلصت الدراسة الى النتائج الآتية: في المجموعة الاؤلى كان متوسط سرعة التثفّل 61ملم\ساعة لدى الإناث و58 ملم\الساعة لدى الذكور ومتوسط قيمة البروتين الارتكاسي( (C 53 ملغ\ل. في المجموعة الثانية كان متوسط سرعة التثفّل 55 ملم\الساعة لدى الإناث و48ملم\الساعة لدى الذكور وبلغ متوسط قيمة البروتين الارتكاسي(C) 76ملغ\ل. في المجموعة الثالثة، كان متوسط سرعة التثفّل 60 ملم\الساعة لدى الإناث و67ملم\الساعة لدى الذكور والبروتين الارتكاسي (C ) 82 ملغ\ل، المجموعة الرابعة كان متوسط سرعة التثفّل76ملم \الساعة لدى الإناث و84ملم\الساعة لدى الذكور. أما البروتين الارتكاسي (C ) فقد بلغ متوسط تركيزه 77ملغ\ل.
The study depended on 300 patients in AL ASSAD`S University Hospital in Lattakia between the years 2005 and 2006. The patients were separated into four groups: the first group, with infectious diseases; the second group with rheumatoid diseases; the third group with hematological diseases; and the Fourth group with different cancers. The goal of the study was to find a relation among the erythrocyte Sedimentation rate and the C-reactive protein and the groups with inflammatory phenomena.
This study reached these results:
1. In the first group, the mid numbers of the erythrocyte Sedimentation rate was 61mlm/h in women and 58 mlm\h in man, and the mid numbers of C - reactive protein was53mg\l.
2. The second group had 28 % from the whole numbers of patients; the mid numbers of the erythrocyte sedimentation rate was 55mlm/h women and 48mlm\h in man; and the mid numbers of C- reactive protein was76mg\l.
3. The third group had 16 % from the whole numbers of patients; the mid numbers of the erythrocyte Sedimentation rate was 60 mlm/h in women and 67mlm\h in man; and the mid numbers of C - reactive protein was 82mg\l.
4. The fourth group had 19.2% from the whole numbers of patients; the mid numbers of the erythrocyte sedimentation rate was76mlm/h in woman and 84mlm\h in man; and the mid numbers of C-reactive protein was 77mg\l.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.